VION Biosciences (“VION”), a life sciences company building differentiated capabilities across research, diagnostics, and drug development workflows, announces the closing of its acquisition of Cellular Technology Limited (“CTL”), a provider of functional immune monitoring analyzers, software, consumables, and services. This strategic acquisition strengthens VION’s goal to support its customers at a critical measurement layer in immune medicine: the ability to quantify functional immune response across translational and clinical workflows.
Read the full article: VION Biosciences Closes Acquisition of CTL, Strengthening Functional Immune Monitoring Capabilities //
Source: https://www.businesswire.com/news/home/20260408109669/en/VION-Biosciences-Closes-Acquisition-of-CTL-Strengthening-Functional-Immune-Monitoring-Capabilities